Área Sanitaria de Coruña y Cee
Área sanitaria
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (111)
2024
-
Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission
npj Parkinson's Disease, Vol. 10, Núm. 1
-
Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity
Journal of Controlled Release, Vol. 372, pp. 295-303
-
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study
Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849
-
Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models
Stem Cell Research and Therapy, Vol. 15, Núm. 1
-
Novel risk loci for COVID-19 hospitalization among admixed American populations
eLife, Vol. 13
-
The role of the brain renin-angiotensin system in Parkinson´s disease
Translational Neurodegeneration, Vol. 13, Núm. 1
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability
Brain, Behavior, and Immunity, Vol. 108, pp. 255-268
-
Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease
Neurobiology of Disease, Vol. 188
-
Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders
Brain Sciences, Vol. 13, Núm. 2
-
Depressive Symptoms and Their Impact on Quality of Life in Parkinson’s Disease: An Exploratory Network Analysis Approach
Journal of Clinical Medicine, Vol. 12, Núm. 14
-
Expanded and Independent Spanish Validation of the MDS-Non Motor Rating Scale
Movement Disorders Clinical Practice, Vol. 10, Núm. 4, pp. 586-595
-
Extracellular Vesicles and Their Renin–Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson’s Disease
Antioxidants, Vol. 12, Núm. 12
-
Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia
Antioxidants, Vol. 12, Núm. 7
-
Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 5000-5014
-
Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group
Parkinson's Disease, Vol. 2023
-
Risk of Cognitive Impairment in Patients With Parkinson’s Disease With Visual Hallucinations and Subjective Cognitive Complaints
Journal of Clinical Neurology (Korea), Vol. 19, Núm. 4, pp. 344-357
-
Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson’s Disease
Journal of Clinical Medicine, Vol. 12, Núm. 4
-
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402
-
Staging Parkinson's disease according to the MNCD classification correlates with caregiver burden
Brain and Behavior, Vol. 13, Núm. 12